Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.


OTCPK:MEDVF - Post by User

Post by Sarb99on Nov 20, 2021 7:13pm
381 Views
Post# 34149936

Deepoil0808 Yes was right but then stepped into wrong side

Deepoil0808 Yes was right but then stepped into wrong side
  1. Medivolve came out with a Net profit, not a loss. 
  2. Also, they closed 2 testing sites in New York, but they seem moving, one of them to Indianapolis. 
  3. Also 4th quarter starts from Oct 1st not Not November. 
  4. If you check the Medivolve appointment system, both California sites you are talking about are as busy as these sites were before the issue. 
  5. Medivolve only offers 3 test combo, so revenue/margin per customer should stay the same. 

Most likely, we will get an update on the 4th quarter testing/revenue numbers on or before the webinar.

 

America’s Covid-19 infections are climbing again, and could soon hit a weekly average of 100,000 cases a day as daily case reports increase more than 20% across the upper midwest.

 

The fresh worsening of the coronavirus pandemic in the US comes as temperatures cool during the approach of winter, forcing people indoors where the virus is believed to spread more readily and may presage another wave. https://www.theguardian.com/us-news/2021/nov/20/us-covid-infections-rise-upper-midwest 

 

An analysis of data from the Centre for Disease Control (CDC) suggests that around 60% of the US population could be entering the winter season with reduced protection against COVID-19. 

 

Those with reduced or no protection, including more than 100 million Americans who have not received the vaccine, make up nearly 60% of the US population, according to NBC News. 

 

The analysis comes after an NBC interview with Dr. Anthony Fauci on Tuesday, where the director of the National Institute of Allergy and Infectious Diseases stated: "What we're starting to see now is an uptick in hospitalizations among people who've been vaccinated but not boosted." 

 

Similar reports came from the White House COVID-19 briefing on Wednesday. Elderly people and residents of long-term care facilities were among the first to be vaccinated last January, said Dr. Rochelle Walensky, the CDC director. 

 

The highest risk remains among the unvaccinated, who are still 11 times more likely to die from COVID-19 than those who are fully vaccinated. 

 

Walensky said US hospitals are experiencing an "increase in emergency department visits among adults 65 and older, which are now again higher than they are for younger age groups." https://www.businessinsider.com/covid-19-us-population-reduced-protection-vaccines-boosters-cdc-2021-11


deepoil0808 wrote: For transparency purposes I am providing this post.  

I made a decision to sell my entire position based on the companies intention for a 1 for 15 reverse stock split and, their intention to raise additonal funds.

My intention was to have a material position in the company  and, to benefit from good results to be announced, which would have sent the stock rallying.

However that has changed with the reverse stock split vote.   It will dilute my position by 15 times and, it also indirectly confirms that company is in need of cash, which to me means they are still at a loss in their operations. 

I had counted on a profit, not a loss. 

Also there is an issue with 3 cubes, 2 in California with authorities and, 1 in Hampton East.   There is also bitter feud with blowfish and, ending of deal was never announced.   Website still shows blowfish.    Plus one last additional point was the failure to close latest PP or, to even announce what happened to it.

But the tip of the iceberg which convinced me to sell is the REVERSE STOCK SPLIT.

Good Luck to the rest of you,

Disappointed but relieved to be out of here.   This board is also very toxic.

My personal opinion, 

<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse